EUVIMEDEUVIMED entdecken
Leserbrief

When a Risk Marker Becomes a Treatment Indication: A Cautionary Note on Sex-Stratified Antiviral Thresholds

Changhong Miao

Clinical Gastroenterology and Hepatology · 2026-07

DOI: 10.1016/j.cgh.2026.07.024 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-07. Verfasst von Changhong Miao. Beteiligte Einrichtung: Tianjin University of Traditional Chinese Medicine, Tianjin, China. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Zitieren

APA

Miao, C. (2026). When a Risk Marker Becomes a Treatment Indication: A Cautionary Note on Sex-Stratified Antiviral Thresholds. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.07.024

Vancouver

Miao C. When a Risk Marker Becomes a Treatment Indication: A Cautionary Note on Sex-Stratified Antiviral Thresholds. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.07.024

BibTeX
@article{Miao2026,
  author = {Miao, Changhong},
  title = {When a Risk Marker Becomes a Treatment Indication: A Cautionary Note on Sex-Stratified Antiviral Thresholds},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1016/j.cgh.2026.07.024}
}
Kostenlos starten →